Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 18Thoracic 1NET 1Head & Neck 1Genitourinary 1Endocrine 1

Conditions

Neuroendocrine Tumors 4Adenoma, Islet Cell 2Tuberous Sclerosis 1Neoplasms 1Gastroenteropancreatic Neuroendocrine Tumors 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Carcinoid Tumor 1

Interventions

Magnetic Resonance Spectroscopy 2Fluorodeoxyglucose F18 2FAPI-46 2Everolimus 2regorafenib 1lanreotide 1gadoteridol 1gadoterate meglumine 1gadolinium ethoxybenzyl DTPA 1gadodiamide 1gadobutrol 1gadobenic acid 1exemestane 1Tirapazamine 1Surveys and Questionnaires 1Sorafenib 1Radiofrequency Ablation 1Quality of Life 1Octreotide 1Neuropsychological Tests 1Injections 1Ethiodized Oil 1E-7386 1Cytidine Triphosphate 1Cryotherapy 1Clinical Trials, Phase II as Topic 1Acupuncture Therapy 1Acupressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Injections × NET × Clear all
NCT07369505 2026-01-27

Sapu003 in Advanced mTOR-sensitive Solid Tumors

SAPU NANO (US) LLC

Phase 1 Recruiting
27 enrolled
EndocrineGastrointestinalGenitourinaryNET

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Tuberous Sclerosis, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡